Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
52 /100
HIGH RISK
Score updated Sep 12, 2026

PACB — Pacific Biosciences of California, Inc. Dilution Risk Tracker

Track PACB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PACB — Get alerts when the score changes →

As of September 12, 2026, Pacific Biosciences of California, Inc. (PACB) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Pacific Biosciences of California, Inc. has a market capitalization of $462.80M, 310.83M shares outstanding, 235 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
65
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 45%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 139% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split model est. 40%
• 50-day avg $1.43 approaching $1 threshold
• 11 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (11mo)
🔔 Track PACB — Get forecast alerts →

Market Data

Market Cap$462.80M
Shares Outstanding310.83M
Float303.44M
Cash$236.87M
Debt$13.53M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore52/100DilutionWatch score record
Shares Outstanding310.83MVerified float table or market cache
Public Float303.44MVerified float table or market cache
Market Cap$462.80MMarket data cache
Cash Runway11.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 1, 4 4, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 4.8% shares (2026Q1 vs prior)
235 institutional holders · 217.52M shares
#1 ARK Investment Management LLC 36.27M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 25.55M shares
#3 BlackRock, Inc. 25.27M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest49.58M
Days to Cover6.8
% of Float16.3%
FINRA data as of Aug 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-06-30
4 INSIDER TRANSACTION 2026-03-05
3 FORM3 2026-03-05
4 INSIDER TRANSACTION 2026-03-04
4 INSIDER TRANSACTION 2026-03-04
Full SEC filing analysis available with free account

Recent News

No recent news

Factual PACB Dilution Snapshot

Pacific Biosciences of California, Inc. (PACB) has a DilutionScore of 52/100, rated High dilution risk. Score date: September 12, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PACB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PACB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,348+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PACB
PACB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.